Epstein-Barr virus nuclear antigen-1 is useful as therapeutic efficacy marker in serum but not in saliva of nasopharyngeal cancer patients who underwent radiotherapy
Research output: Contribution to journal › Article › peer-review
6Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Epstein-Barr virus nuclear antigen-1 is useful as therapeutic efficacy marker in serum but not in saliva of nasopharyngeal cancer patients who underwent radiotherapy'. Together they form a unique fingerprint.